Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine nasal spray for acute 'off' symptoms in advanced Parkinson's disease
2005-004290-19Phase 2Completed
- Sponsor
- Schwarz Pharma
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Rotigotine nasal spray with Placebo nasal spray (2 arms). Primary endpoint: Adverse events. Started Dec 2005; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-004290-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004290-19.